TRIP13 and prostate cancer: found that prostate cancer cell lines and tissues significantly reduce the expression of miR-515-5p, whereas its overexpression negatively regulates tumor cell proliferation and migratory characteristics by binding to thyroid hormone receptor interactor 13 (TRIP13), as a tumor promoter.